Oner P, Oztaş B, Koçak H
Department of Biochemistry, Istanbul Faculty of Medicine, University of Istanbul, Turkey.
Pharmacol Res. 1997 Jul;36(1):69-72. doi: 10.1006/phrs.1997.0208.
The aim of this study was to investigate the brain cortex Na(+)-K+ ATPase activity in rats made diabetic by streptozotocin and epileptic by pentylenetetrazol. Streptozotocin diabetic rats showed a significant decrease in brain cortex Na(+)-K+ ATPase activity whereas the pentylenetetrazol treatment caused no significant change in enzyme activity. On the other hand, no brain cortex Na(+)-K+ ATPase activity could be detected in all the diabetic rats treated with pentylenetetrazol. Our results concluded that reduced Na(+)-K+ ATPase activity in streptozotocin diabetic rats may contribute to the pathogenesis of metabolic complications of the central nervous system, and that the undetectable enzyme activity in diabetic convulsing rats may result from considerable damage or necrosis of brain tissue during pentylenetetrazol seizures.
本研究旨在调查用链脲佐菌素诱导糖尿病并用戊四氮诱导癫痫的大鼠大脑皮层钠钾ATP酶活性。链脲佐菌素诱导的糖尿病大鼠大脑皮层钠钾ATP酶活性显著降低,而戊四氮处理对酶活性无显著影响。另一方面,在用戊四氮处理的所有糖尿病大鼠中均未检测到大脑皮层钠钾ATP酶活性。我们的结果表明,链脲佐菌素诱导的糖尿病大鼠钠钾ATP酶活性降低可能导致中枢神经系统代谢并发症的发病机制,而糖尿病惊厥大鼠中无法检测到酶活性可能是由于戊四氮惊厥期间脑组织的严重损伤或坏死所致。